Quarterly report pursuant to Section 13 or 15(d)

Securities Financing Agreements, Collateral and Restricted Cash - Securities Financing Agreements (Details)

v3.23.1
Securities Financing Agreements, Collateral and Restricted Cash - Securities Financing Agreements (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Securities borrowed or purchased under agreements to resell    
Gross Assets/Liabilities $ 633,124 $ 597,847
Amounts Offset (335,046) (330,273)
Net Balance Sheet Amount 298,078 267,574
Financial Instruments (268,791) (240,120)
Net Assets/Liabilities 29,287 27,454
Securities loaned or sold under agreements to repurchase    
Gross Liabilities 649,426 525,908
Amounts Offset (335,046) (330,273)
Net Balance Sheet Amount 314,380 195,635
Financial Instruments (287,074) (183,265)
Net Liabilities 27,306 12,370
Other    
Gross Liabilities 11,993 8,427
Amounts Offset 0 0
Net Balance Sheet Amount 11,993 8,427
Financial Instruments (11,993) (8,427)
Net Liabilities 0 0
Total Securities Financing Agreements Liability    
Gross Liabilities 661,419 534,335
Amounts Offset (335,046) (330,273)
Net Balance Sheet Amount 326,373 204,062
Financial Instruments (299,067) (191,692)
Net Liabilities 27,306 12,370
Loans and leases repurchase activity $ 9,900 $ 8,700